CBCHi001-A-1

The cell line is not validated yet.

General#

Cell Line

hPSCreg Name
CBCHi001-A-1
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 1st April 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Beijing Chest Hospital (CBCH)

External Databases

BioSamples SAMEA13855333

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research: allowed
Clinical: not allowed
Commercial: not allowed
Subclone of

Donor Information#

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

External Databases (Donor)

BioSamples SAMEA13855308

Ethics#

Also have a look at the ethics information for the parental line CBCHi001-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation#

General

The source cell information can be found in the parental cell line CBCHi001-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions#

Medium mTeSR™ Plus

Characterisation#

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
SOX2
Yes
SSEA-4
Yes
Score:
Marker Present Absent
mCpG
OCT4
Differentiation Potency

Genotyping#

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification#

Disease/phenotype related modifications
Hypertrophic Cardiomyopathy
Synonyms
  • Hypertrophic Cardiomyopathy
Genetic modifications
Variant
15q14
NM_005159.5:c.715G>C